Some glucose-lowering drugs reduce risk for major adverse cardiac events.
| Title | Some glucose-lowering drugs reduce risk for major adverse cardiac events. |
| Publication Type | Journal Article |
| Year of Publication | 2020 |
| Authors | Liakos, A., Tsapas A., & Bekiari E. |
| Journal | Ann Intern Med |
| Volume | 173 |
| Issue | 2 |
| Pagination | JC9 |
| Date Published | 2020 07 21 |
| ISSN | 1539-3704 |
| Keywords | Blood Glucose, Glucose, Heart, Humans, Hypoglycemic Agents, Sodium-Glucose Transporter 2 Inhibitors |
| Abstract | SOURCE CITATION: Zhu J, Yu X, Zheng Y, et al. Lancet Diabetes Endocrinol. 2020;8:192-205. 32006518. |
| DOI | 10.7326/ACPJ202007210-010 |
| Alternate Journal | Ann Intern Med |
| PubMed ID | 32687745 |
